AVP and metabolic syndrome: As copeptin levels have also been associated with additional metabolic effects including lipid oxidation hyperinsulinaemia, metabolic syndrome and future type 2 diabetes, the observed changes in copeptin in our study might encompass additional physiologic processes besides haemodynamic control.49, 50